Transforming Growth Factor-alpha Induces the Differentiation of Sarcomatoid Cholangiocarcinoma Cells

Overview

Journal Jpn J Cancer Res

Specialty Oncology

Date 2000 Apr 13

PMID 10761710

Authors

M Enjoji

M Nakashima

M Nakamuta

H Nawata

Affiliations

Soon will be listed here.

Abstract

A sarcomatoid cholangiocarcinoma cell line, ETK-1, was established from a patient. Phenotypically, the cells corresponded to immature biliary epithelial cells. Because a small number of ETK-1 cells appeared to differentiate spontaneously along a biliary epithelial lineage in continuous culture, we examined the factors that initiate and/or promote the differentiation of the cells. Transforming growth factor-alpha (TGFalpha) induced significant changes in ETK-1 cells. After stimulation with the factor, ETK-1 cells displayed morphologic transformation at a much higher frequency, with the appearance of many large cells with intracytoplasmic vacuoles, and the production of mucinous substances. These morphologically transformed cells were phenotypically similar to well-differentiated adenocarcinoma cells. The expression pattern of integrins after TGFalpha treatment also supported the maturation of the ETK-1 cells. The antibody against the receptor of TGFalpha inhibited these changes by TGFalpha. Moreover, the proliferation rate of ETK-1 cells was suppressed by TGFalpha. Our data suggest that TGFalpha can act as a differentiation factor along a biliary epithelial lineage.

References

Volpes R, van den Oord J, Desmet V . Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol. 1993; 142(5):1483-92. PMC: 1886895. View

Volpes R, van den Oord J, Desmet V . Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology. 1991; 101(1):200-6. DOI: 10.1016/0016-5085(91)90478-4. View

Sell S, Dunsford H . Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol. 1989; 134(6):1347-63. PMC: 1879951. View

Schreiber A, Winkler M, Derynck R . Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science. 1986; 232(4755):1250-3. DOI: 10.1126/science.2422759. View

Haratake J, Yamada H, Horie A, Inokuma T . Giant cell tumor-like cholangiocarcinoma associated with systemic cholelithiasis. Cancer. 1992; 69(10):2444-8. DOI: 10.1002/1097-0142(19920515)69:10<2444::aid-cncr2820691010>3.0.co;2-r. View

Terada T, Nakanuma Y . Development of human intrahepatic peribiliary glands. Histological, keratin immunohistochemical, and mucus histochemical analyses. Lab Invest. 1993; 68(3):261-9. View

Alison M, Nasim M, Anilkumar T, Sarraf C . Transforming growth factor-alpha immunoreactivity in a variety of epithelial tissues. Cell Prolif. 1993; 26(5):449-60. DOI: 10.1111/j.1365-2184.1993.tb00132.x. View

Lee D, Rochford R, Todaro G, Villarreal L . Developmental expression of rat transforming growth factor-alpha mRNA. Mol Cell Biol. 1985; 5(12):3644-6. PMC: 369199. DOI: 10.1128/mcb.5.12.3644-3646.1985. View

Germain L, Noel M, Gourdeau H, Marceau N . Promotion of growth and differentiation of rat ductular oval cells in primary culture. Cancer Res. 1988; 48(2):368-78. View

10.

Gomez-Lechon M, Castelli J, Guillen I, OConnor E, Nakamura T, Fabra R . Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture. Hepatology. 1995; 21(5):1248-54. View

11.

Honda M, Enjoji M, Sakai H, Yamamoto I, Tsuneyoshi M, Nawata H . Case report: intrahepatic cholangiocarcinoma with rhabdoid transformation. J Gastroenterol Hepatol. 1996; 11(8):771-4. DOI: 10.1111/j.1440-1746.1996.tb00330.x. View

12.

Webber E, FitzGerald M, Brown P, Bartlett M, Fausto N . Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. Hepatology. 1993; 18(6):1422-31. View

13.

Evarts R, Nakatsukasa H, Marsden E, Hu Z, Thorgeirsson S . Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Mol Carcinog. 1992; 5(1):25-31. DOI: 10.1002/mc.2940050107. View

14.

Fujio K, Evarts R, Hu Z, Marsden E, Thorgeirsson S . Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest. 1994; 70(4):511-6. View

15.

Sigal S, Brill S, Fiorino A, Reid L . The liver as a stem cell and lineage system. Am J Physiol. 1992; 263(2 Pt 1):G139-48. DOI: 10.1152/ajpgi.1992.263.2.G139. View

16.

Marsden E, Hu Z, Fujio K, Nakatsukasa H, Thorgeirsson S, Evarts R . Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest. 1992; 67(4):427-33. View

17.

Marceau N . Cell lineages and differentiation programs in epidermal, urothelial and hepatic tissues and their neoplasms. Lab Invest. 1990; 63(1):4-20. View

18.

Brown P, Lam R, Lakshmanan J, Fisher D . Transforming growth factor alpha in developing rats. Am J Physiol. 1990; 259(2 Pt 1):E256-60. DOI: 10.1152/ajpendo.1990.259.2.E256. View

19.

Lee G, Merlino G, Fausto N . Development of liver tumors in transforming growth factor alpha transgenic mice. Cancer Res. 1992; 52(19):5162-70. View

20.

Enjoji M, Nakashima M, Honda M, Sakai H, Nawata H . Hepatocytic phenotypes induced in sarcomatous cholangiocarcinoma cells treated with 5-azacytidine. Hepatology. 1997; 26(2):288-94. DOI: 10.1002/hep.510260206. View